InsidersTradesSigma
HilleVax, Inc.: management transactions · United States · SEC (Form 4)
SEC:hillevax-inc-489104US·SEC (Form 4)Mcap 777.8Bn€Technology
Browse the full directors' dealings record of HilleVax, Inc., a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Technology sector, HilleVax, Inc. has recorded 1 insider filings. Market capitalisation: €777.8bn. The latest transaction was reported on 3 May 2022 (C). Among the most active insiders: Frazier Life Sciences X, L.P.. The full history is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended August 2025 · cache
689.84 €
Analyst consensus
41 analystsStrong buy
249.00 €Target 584.24 €(-15%)1000.00 €
Income statement
Revenue37.38 Bn€
Gross profit14.87 Bn€40% margin
Net income8.54 Bn€41.5% margin
Valuation
PER (trailing)32.6x
PER (forward)6.7x
P/Book10.7x
Beta1.92
Balance sheet & cash
Market cap777.84 Bn€
Total debt15.28 Bn€
Free Cash Flow1.67 Bn€
Debt / Equity15%
Profitability & ownership
ROE39.8%
ROA20.1%
% insiders0.3%
% institutions81.1%
Last declaration on 3 May 2022
Declarations1 total
Executives●C16SEC
€35m2,736,234 shares@ €12.91730.0045% mcap100.0% of flow
Common Stock
SEC:0000899243-22-016310:0·
1 of 1 declaration